ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Chart Show 1980 Budget Breakown By Mechanisms, Research Programs, Compare Them With Previous Years

June 9, 1978

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

March 25, 2011

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

NCAB Commends Garb for His Contributions

December 11, 1981

Trial Tests Virtual Colonoscopy Vs. Standard; Polyp Study Favors Colonoscopy Over Barium

August 25, 2000